SCHEMBL4649417

SCHEMBL4649417

Cc1cccc2c(=O)cc(-c3ccccc3)oc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 6/20 0.63
CYP3A4 P08684 6/20 0.63
CYP1A2 P05177 6/20 0.63
HPGD P15428 5/20 0.63
CYP1A1 P04798 5/20 0.63
CYP19A1 P11511 5/20 0.63
TP53 P04637 4/20 0.63
ALDH1A1 P00352 4/20 0.63
MAPT P10636 4/20 0.63
KDM4E B2RXH2 3/20 0.63
HSD17B10 Q99714 3/20 0.63
CYP2C19 P33261 3/20 0.63
ABCB1 P08183 2/20 0.63
ABCG2 Q9UNQ0 2/20 0.63
MAPK1 P28482 2/20 0.63
CYP2C9 P11712 2/20 0.63
CYP2D6 P10635 2/20 0.63
PDE5A O76074 1/20 0.63
TSHR P16473 1/20 0.63
CYP2B6 P20813 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9328540 0.85 CYP1A1 (0.67) CYP1B1CYP1A2CYP1A1PRKDCGABRP
SCHEMBL535362 0.84 CYP1A1 (0.68) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
SCHEMBL27676687 0.82 CYP1A2 (0.65) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
SCHEMBL29307653 0.81 CYP1A2 (0.63) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
SCHEMBL13264829 0.81 CYP1B1 (0.60) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
SCHEMBL22032708 0.81 CYP1B1 (0.63) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
SCHEMBL8934600 0.81 CYP19A1 (0.70) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
Flavone SCHEMBL27686205 0.81 TNKS (0.84) CYP1B1CYP3A4HPGDCYP19A1TP53
SCHEMBL22032736 0.80 CYP1B1 (0.58) CYP1B1CYP3A4CYP1A2HPGDCYP1A1
8-Methoxyflavone SCHEMBL26180800 0.80 ALDH1A1 (0.74) CYP1B1CYP3A4CYP1A2HPGDCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
US-8734865-B2 Lupin total extract consisting of a lupin sugar extract and a lupin peptide extract, method for the production and use thereof LABORATOIRES EXPANSCIENCE (FR) 2014-05-27 US disclosed
US-8734865-B2 Lupin total extract consisting of a lupin sugar extract and a lupin peptide extract, method for the production and use thereof LABORATOIRES EXPANSCIENCE (FR) 2014-05-27 US disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
US-7763647-B2 Topical solution containing a chromane or chromene derivative LABORATORIES EXPANSCIENCE (FR) 2010-07-27 US disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-7345068-B2 Aromatic amino acid derivatives and medicinal compositions Endou, Hitoshi (JP) 2008-03-18 US disclosed
US-7323458-B1 Dihydrobenzodiazepins and their use for treating dyslipidemia MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-01-29 US disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP CYP1B1 1640/4885CYP3A4 3010/4885CYP1A2 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.